Suzetrigine (Journavx)

DRUG3 trials

Sponsors

Ohio State University, University of Alabama at Birmingham, Beth Israel Deaconess Medical Center

Conditions

Artroscopic SurgeryHip Fractures (ICD-10 72.01-72.2)Opioid ConsumptionOpioid Consumption, PostoperativePain After Shoulder SurgeryPain ManagementPost Operative AnalgesiaPostoperative Pain

Phase 4

Suzetrigine (Journavx) for Pain Management After Spine Surgery

Not yet recruitingNCT07829718

Ohio State UniversityPostoperative Pain, Spine Fusion

Start: 2026-09-13End: 2030-12-30Target: 110Updated: 2026-09-21

Suzetrigine for Analgesiain Arthroscopic Rotator Cuff Repair

Not yet recruitingNCT07866638

University of Alabama at BirminghamArtroscopic Surgery, Opioid Consumption, Opioid Consumption, Postoperative +2

Start: 2026-11-01End: 2028-09-01Target: 100Updated: 2026-10-08

Suzetrigine (Journavx) as Multimodal Therapy for Pain Management in Adults Undergoing Surgery for Hip Fracture

Not yet recruitingNCT07905404

Beth Israel Deaconess Medical CenterHip Fractures (ICD-10 72.01-72.2), Post Operative Analgesia

Start: 2027-01-05End: 2028-07-30Target: 79Updated: 2026-10-29